A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis

DSpace Repository

A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis

Author: Konstan, M. W.; Doering, G.; Heltshe, S. L.; Lands, L. C.; Hilliard, K. A.; Koker, P.; Bhattacharya, S.; Staab, A.; Hamilton, A.
Tübinger Autor(en):
Döring, Gerd
Published in: Journal of Cystic Fibrosis (2014), Bd. 13, H. 2, S. 148-155
Verlagsangabe: Elsevier Science Bv
Language: English
Full text: http://dx.doi.org/10.1016/j.jcf.2013.12.009
ISSN: 1569-1993
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)